233 related articles for article (PubMed ID: 33050993)
1. Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia.
Tiscornia JE; Poggio TV; Feinsilber DG; Coleman AE
Skinmed; 2020; 18(4):254-255. PubMed ID: 33050993
[No Abstract] [Full Text] [Related]
2. Proposed use of thalidomide for the cytokine storm of COVID-19.
Goihman-Yahr M
Clin Dermatol; 2020; 38(4):508. PubMed ID: 32972614
[No Abstract] [Full Text] [Related]
3. Investigating hypothiocyanite against SARS-CoV-2.
Cegolon L
Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009
[No Abstract] [Full Text] [Related]
4. Evaluation of Potential Therapeutic Options for COVID-19.
Austin D; Okour M
J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
[No Abstract] [Full Text] [Related]
5. Treatments for COVID-19: where are we now?
Mendes A
Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
[No Abstract] [Full Text] [Related]
6. Curing COVID-19.
The Lancet Infectious Diseases
Lancet Infect Dis; 2020 Oct; 20(10):1101. PubMed ID: 32919520
[No Abstract] [Full Text] [Related]
7. Treatment considerations for coronavirus (COVID-19).
Reilly J
Hosp Pract (1995); 2020 Aug; 48(3):119-120. PubMed ID: 32282262
[No Abstract] [Full Text] [Related]
8. Favipiravir, an antiviral for COVID-19?
Coomes EA; Haghbayan H
J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
[No Abstract] [Full Text] [Related]
9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
10. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management.
Fekrazad R
Photobiomodul Photomed Laser Surg; 2020 May; 38(5):255-257. PubMed ID: 32326830
[No Abstract] [Full Text] [Related]
11. Sofosbuvir as a potential option for the treatment of COVID-19.
Nourian A; Khalili H
Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
[TBL] [Abstract][Full Text] [Related]
12. Antivirals for COVID-19 and Breastfeeding.
Anderson PO
Breastfeed Med; 2020 Oct; 15(10):605-607. PubMed ID: 32936682
[No Abstract] [Full Text] [Related]
13. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
14. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
Cairoli E; Espinosa G
Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
[No Abstract] [Full Text] [Related]
15. Chloroquine for COVID-19: rationale, facts, hopes.
Cortegiani A; Ippolito M; Ingoglia G; Einav S
Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
[No Abstract] [Full Text] [Related]
16. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
17. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
18. Plea for multitargeted interventions for severe COVID-19.
Gaborit BJ; Bergmann JF; Mussini C; Arribas JR; Behrens G; Walmsley S; Pozniak A; Raffi F
Lancet Infect Dis; 2020 Oct; 20(10):1122-1123. PubMed ID: 32325035
[No Abstract] [Full Text] [Related]
19. Famotidine Against SARS-CoV2: A Hope or Hype?
Ghosh R; Chatterjee S; Dubey S; Lavie CJ
Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
[No Abstract] [Full Text] [Related]
20. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
Kalil AC
JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
